Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4FV9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,783
Award facts
- Contract value 100% obligated
- $13,783.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $13,783.13. This firm fixed-price delivery order, with an ultimate completion date of December 31, 2025, represents a competitively awarded non-set-aside contract supporting federal pharmaceutical procurement needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Department of Defense and other government healthcare systems. The company's performance under its prime IDV demonstrates capability to deliver diverse pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for Otezla, a prescription medication used in dermatology and rheumatology, reflects the company's ongoing role in supporting military healthcare procurement through the DLA Troop Support Medical's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F4FV9?
SPE2DR26F4FV9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F4FV9 worth?
The government has obligated $13,783 on SPE2DR26F4FV9.
Is contract SPE2DR26F4FV9 an order under another contract?
Yes. SPE2DR26F4FV9 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4FV9 competed?
The extent of competition for SPE2DR26F4FV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award